News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
GENESIS Biomed contribuye a la estructuración de estrategias de crecimiento en KYMOS y otras empresas catalanas a través del programa NON ACCIÓ
GENESIS Biomed contributes to the development of growth strategies for KYMOS and other Catalan companies through the NON ACCIÓ programme
Healthcare · Financing · Corporate
ACCIÓ’s Noves Oportunitats de Negoci calls for proposals provide Catalan companies with a…
Partners - GENESIS Biomed
Consejo Europeo
The European Council advances the Biotech Act I legislative process
International · EU projects
The EU EPSCO Council took a step forward in the legislative process of the Biotech Act I by…
Alfonso de Egaña, CEO de Molefy Pharma
World ALS Day | “ALS research is currently going through a particularly promising moment”
Healthcare · Rare diseases · Innovative drugs · Personalized medicine
We interview Alfonso de Egaña Barrenechea, CEO of Molefy Pharma, a company developing AP-2, an…
AseBio - MOLEFY PHARMA
Científico analizando plantas
AseBio welcomes the European Parliament’s approval of New Genomic Techniques
Climate change · Agrifood · Food & feed · Agriculture
For AseBio, the agreement marks a significant step towards a modern, science-based regulatory…
Shilpa Biocare invierte en Gate2Brain para impulsar G2B-002, un innovador candidato terapéutico para el cáncer cerebral
Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Therapeutic Candidate
Healthcare · Rare diseases · Innovative drugs
Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for…
Partners - Gate2Brain
Unión Europea
AseBio is involved in three key European initiatives aimed at boosting biotechnology competitiveness and scaling
Industrial biotechnology · International · Financing
We have contributed to the Fraunhofer Institute’s technical questionnaire on the Biotech Act II,…
El Parc Científic de la Universidad de Barcelona alcanza una inversión histórica de 230 millones de euros en 2025
The University of Barcelona Science Park reaches a new investment record of €230 million in 2025
Healthcare · Innovative drugs · Financing
The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in…
Partners - Parc Científic de Barcelona
LOGO STABLEPHARMA
Stablepharma and AFT Move to Expand Fridge-Free Vaccine Distribution Following Positive Clinical Data
Healthcare · Innovative drugs · International
Potential agreement follows positive clinical and stability data, supporting rollout in UK, Canada,…
Partners - STABLEPHARMA
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
Healthcare · Drug discovery · Innovative drugs
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels…
Partners - Oryzon Genomics